Platelet Immune Responses in Aging and Influenza
衰老和流感中的血小板免疫反应
基本信息
- 批准号:8625156
- 负责人:
- 金额:$ 37.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-06-01 至 2019-05-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAgingAgonistAntibody FormationBlood PlateletsCellsCellular MembraneClinicalCytoplasmic GranulesDataDevelopmentDiseaseEffector CellElderlyFamilyFamily memberFunctional disorderGene Expression ProfileGenesGrantHumanImmuneImmune responseImpairmentInfluenzaInfluenza A Virus, H1N1 SubtypeInfluenza vaccinationIntegral Membrane ProteinInterferonsInvestigationMaintenanceMediatingMegakaryocytesMembraneModelingMorbidity - disease rateOutcomePathogenesisPathway interactionsPatientsPatternPost-Transcriptional RegulationPredispositionPreventionProtein FamilyProteinsProteomeRNA SequencesRecordsResearchResearch PersonnelRiskRoleScientistSeverity of illnessTechniquesViralVirus DiseasesVirus Replicationadverse outcomeage relatedbasebench to bedsideclinically relevanthigh riskhuman IFITM1 proteinhuman subjectimmune functionimmunosenescenceimprovedinfluenzavirusmortalityolder patientpreventprotein expressionpublic health relevancerespiratoryresponsetooltranscriptome sequencing
项目摘要
DESCRIPTION (provided by applicant): Platelets are emerging as dynamic and versatile immune effector cells that mediate host responses to respiratory viral infections, including influenza. In the elderly, influenza infections are common and cause substantial morbidity and mortality. Our grant, entitled "Platelet Immune Responses in Aging and Influenza" will examine age-related changes in newly-discovered platelet immune proteins and how impaired responses contribute to adverse clinical outcomes. This family of proteins, the interferon-induced transmembrane proteins (IFITMs), prevents influenza viral replication and infectivity. IFITM family members have not previously been described in human platelets. Our specific aims and hypotheses are based on a rich pool of preliminary data demonstrating that platelets from older adults have diminished expression of IFITMs during influenza infection and following influenza vaccination. We also found that the inability to upregulate IFITM protein expression correlates with an increased risk of influenza-related mortality. In our preliminary studies, there is evidenc that expression of IFITM occurs at transcriptional and post-transcriptional checkpoints in platelet
precursors (e.g., megakaryocytes) and mature platelets. In this application, we will determine, in settings of influenza infection and following influenza vaccination, whether aging alters the induction of IFITM proteins in human platelets. We will also establish whether age-related impairments in IFITM induction contribute to influenza-related illness severity and mortality. Moreover, we will dissect the mechanisms and patterns of IFITM expression in human platelets and model megakaryocytes derived from young and older human subjects. While we will investigate IFITM family members in detail, we will also use deep RNA-sequencing (RNA-seq) to identify other candidate immunomodulatory genes in platelets and megakaryocytes that are altered in older adults. Candidates identified by RNA-seq will be examined in-depth at the message, protein, and/or activity level. These investigations are the first studies to characterize
IFITMs in megakaryocytes and platelets. As our investigations will be accomplished using human subjects and primary human cells, our findings will have immediate clinical relevance. Our multi-disciplinary team unites young and senior investigators, clinicians, and basic scientists. All techniques and tools are established and in place and we have proven track records of paradigm-shifting, bench-to-bedside discovery research. Thus, we are poised to determine how aging alters immune sensing by platelets and megakaryocytes and define new mechanisms regulating influenza-induced platelet immune responses in the elderly.
描述(由申请人提供):血小板是一种动态和多功能的免疫效应细胞,介导宿主对呼吸道病毒感染(包括流感)的反应。在老年人中,流感感染很常见,并导致大量发病率和死亡率。我们的拨款题为“衰老和流感中的血小板免疫反应”,将研究新发现的血小板免疫蛋白的年龄相关变化,以及受损的反应如何导致不良的临床结果。这个蛋白家族,干扰素诱导的跨膜蛋白(IFITMs),可以阻止流感病毒的复制和传染性。IFITM家族成员以前未在人类血小板中被描述。我们的具体目标和假设是基于丰富的初步数据,这些数据表明,在流感感染期间和流感疫苗接种后,老年人的血小板中ifitm的表达减少。我们还发现,无法上调IFITM蛋白表达与流感相关死亡风险增加相关。在我们的初步研究中,有证据表明IFITM的表达发生在血小板的转录和转录后检查点
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Matthew Thomas Rondina其他文献
Matthew Thomas Rondina的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Matthew Thomas Rondina', 18)}}的其他基金
Translational Control of Megakaryocyte and Platelet Function in Sepsis
脓毒症中巨核细胞和血小板功能的转化控制
- 批准号:
9577464 - 财政年份:2018
- 资助金额:
$ 37.24万 - 项目类别:
Platelet Translational Control Mechanisms in Stroke and Vascular Cognitive Dementia
中风和血管性认知痴呆中的血小板翻译控制机制
- 批准号:
10281770 - 财政年份:2018
- 资助金额:
$ 37.24万 - 项目类别:
Translational Control of Megakaryocyte and Platelet Function in Sepsis
脓毒症中巨核细胞和血小板功能的转化控制
- 批准号:
10210293 - 财政年份:2018
- 资助金额:
$ 37.24万 - 项目类别:
Platelet Immune Responses in Aging and Influenza
衰老和流感中的血小板免疫反应
- 批准号:
9282389 - 财政年份:2014
- 资助金额:
$ 37.24万 - 项目类别:
Platelet Immune Responses in Aging and Influenza
衰老和流感中的血小板免疫反应
- 批准号:
8852034 - 财政年份:2014
- 资助金额:
$ 37.24万 - 项目类别:
The Regulation of Inflammatory Gene Responses in Aging
衰老过程中炎症基因反应的调节
- 批准号:
8183844 - 财政年份:2011
- 资助金额:
$ 37.24万 - 项目类别:
相似海外基金
Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
- 批准号:
24K18114 - 财政年份:2024
- 资助金额:
$ 37.24万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
- 批准号:
10089306 - 财政年份:2024
- 资助金额:
$ 37.24万 - 项目类别:
Collaborative R&D
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
- 批准号:
498288 - 财政年份:2024
- 资助金额:
$ 37.24万 - 项目类别:
Operating Grants
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
- 批准号:
498310 - 财政年份:2024
- 资助金额:
$ 37.24万 - 项目类别:
Operating Grants
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
- 批准号:
23K20339 - 财政年份:2024
- 资助金额:
$ 37.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
- 批准号:
2740736 - 财政年份:2024
- 资助金额:
$ 37.24万 - 项目类别:
Studentship
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
- 批准号:
2406592 - 财政年份:2024
- 资助金额:
$ 37.24万 - 项目类别:
Standard Grant
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
- 批准号:
2305890 - 财政年份:2024
- 资助金额:
$ 37.24万 - 项目类别:
Fellowship Award
虚弱高齢者のSuccessful Agingを支える地域課題分析指標と手法の確立
建立区域问题分析指标和方法,支持体弱老年人成功老龄化
- 批准号:
23K20355 - 财政年份:2024
- 资助金额:
$ 37.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
「ケア期間」に着目したbiological aging指標の開発
开发聚焦“护理期”的生物衰老指数
- 批准号:
23K24782 - 财政年份:2024
- 资助金额:
$ 37.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B)